SEC Form 4 · accession 0001645627-17-000058
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 12:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2017 | P | 1,000 | $0.0689 | A | 20,673,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.069 | A | 20,674,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.069 | A | 20,675,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.068 | A | 20,676,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.067 | A | 20,677,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.065 | A | 20,678,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.067 | A | 20,679,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.067 | A | 20,680,949 | D | |
| Common Stock | May 9, 2017 | P | 1,000 | $0.067 | A | 20,681,949 | D | |
| Common Stock | May 10, 2017 | P | 1,000 | $0.061 | A | 20,682,949 | D | |
| Common Stock | May 10, 2017 | P | 1,000 | $0.062 | A | 20,683,949 | D | |
| Common Stock | May 10, 2017 | P | 1,000 | $0.062 | A | 20,684,949 | D | |
| Common Stock | May 10, 2017 | P | 1,000 | $0.061 | A | 20,685,949 | D |
Table II — derivative securities
No Table II lines on this filing.